Processing

Please wait...

Settings

Settings

1. WO1996004241 - BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS

Publication Number WO/1996/004241
Publication Date 15.02.1996
International Application No. PCT/JP1995/001479
International Filing Date 25.07.1995
Chapter 2 Demand Filed 05.03.1996
IPC
C07C 279/22 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
279Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups
20containing any of the groups X being a hetero atom, Y being any atom, e.g. acylguanidines
22Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
C07D 209/08 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
209Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
02condensed with one carbocyclic ring
04Indoles; Hydrogenated indoles
08with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
C07D 215/14 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
215Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
02having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
12with substituted hydrocarbon radicals attached to ring carbon atoms
14Radicals substituted by oxygen atoms
C07D 217/02 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
217Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
02with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
C07D 241/42 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
241Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
36condensed with carbocyclic rings or ring systems
38with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
40Benzopyrazines
42with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
C07D 263/56 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
263Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
52condensed with carbocyclic rings or ring systems
54Benzoxazoles; Hydrogenated benzoxazoles
56with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
CPC
A61P 13/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
02of urine or of the urinary tract, e.g. urine acidifiers
A61P 15/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
15Drugs for genital or sexual disorders
A61P 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
A61P 9/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
10for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
C07C 2601/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
2601Systems containing only non-condensed rings
06with a five-membered ring
10the ring being unsaturated
C07C 2602/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
2602Systems containing two condensed rings
02the rings having only two atoms in common
04One of the condensed rings being a six-membered aromatic ring
10the other ring being six-membered, e.g. tetraline
Applicants
  • FUJISAWA PHARMACEUTICAL CO., LTD. [JP/JP]; 4-7, Doshomachi 3-chome Chuo-ku Osaka-shi Osaka 541, JP (AllExceptUS)
  • KUNO, Atsushi [JP/JP]; JP (UsOnly)
  • MIZUNO, Hiroaki [JP/JP]; JP (UsOnly)
  • YAMASAKI, Kumi [JP/JP]; JP (UsOnly)
  • INOUE, Yoshikazu [JP/JP]; JP (UsOnly)
Inventors
  • KUNO, Atsushi; JP
  • MIZUNO, Hiroaki; JP
  • YAMASAKI, Kumi; JP
  • INOUE, Yoshikazu; JP
Agents
  • SEKI, Hideo; Fujisawa Pharmaceutical Co., Ltd. Osaka Factory 1-6, Kashima 2-chome Yodogawa-ku, Osaka-shi Osaka 532, JP
Priority Data
9415852.405.08.1994GB
9422830.111.11.1994GB
9505231.215.03.1995GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS
(FR) DERIVES DE BENZOYLGUANIDINE UTILISES EN TANT QUE MEDICAMENTS
Abstract
(EN)
Guanidine derivatives of formula (I) wherein R1 is hydrogen, hydroxy(lower)alkyl, protected hydroxy(lower)alkyl, acyl(lower)alkoxy, acyl(lower)alkenyl, or acyl, and R2 is ar(lower)alkenyl; aryl substituted with two suitable substituents; indenyl, indanyl, dihydrobenzocycloheptenyl, di(or tetra or hexa or octa or deca)hydronaphthyl, cyclopentenyl, dihydrothienyl, dihydrofuryl or heterobicyclic group, each of which may have suitable substituent(s); lower alkylthienyl; mono(or di)halothienyl; mono(or di or tri)halo(lower)alkylthienyl; acylthienyl; halofuryl; or mono(or di or tri)halo(lower)alkylfuryl; and a pharmaceutically acceptable salt thereof, which is useful as a medicament.
(FR)
L'invention se rapporte à des dérivés de guanidine de la formule (I) dans laquelle R1 représente hydrogène, hydroxy-alkyle(inférieur), hydroxy-alkyle(inférieur) protégé, acyle-alcoxy(inférieur), acyle-alcényle(inférieur), ou acyle, et R2 représente ar alcényle(inférieur); aryle substitué par deux substituants appropriés; indényle, indanyle, dihydrobenzocycloheptényle, di(ou tétra ou hexa ou octa ou déca)hydronaphtyle, cyclopentényle, dihydrothiényle, un groupe dihydrofuryle ou hétérobicyclique, chacun d'eux pouvant être un ou des substituants appropriés; alkylthiényle inférieur; mono (ou di)halothiényle; mono(ou di ou tri)halo alkylthiényle(inférieur); acylthiényle; halofuryle; ou mono(ou di ou tri)halo alkylefuryle(inférieur). L'invention se rapporte également à un sel pharmaceutiquement acceptable de ces dérivés qui est utilisé comme médicament.
Latest bibliographic data on file with the International Bureau